Xingqi Eye Medicine (300573.SZ): SQ-25012 Injection Receives Clinical Trial Approval Notice

Zhitong Finance APP news, Xingqi Eye Medicine (300573.SZ) announced that recently, the company received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration regarding SQ-25012 injection, agreeing to conduct clinical trials of this product for the proposed treatment of thyroid eye disease.